Early-start antiplatelet therapy after operation in patients with spontaneous intracerebral hemorrhage and high risk of ischemic events (E-start): Protocol for a multi-centered, prospective, open-label, blinded endpoint randomized controlled trial

BACKGROUND: For severe spontaneous intracerebral hemorrhage (sSICH) patients with high risk of ischemic events, the incidence of postoperative major cardiovascular/cerebrovascular and peripheral vascular events (MACCPE) is notable. Although antiplatelet therapy is a potential way to benefit these pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Kaiwen, Mo, Shaohua, Liu, Qingyuan, Pu, Jun, Huang, Xiaobin, Kang, Dezhi, Lin, Fixin, Zou, Dewei, Sun, Xinguo, Ren, Jinrui, Tong, Xianzeng, Li, Jiangan, Salman, Rustam Al-Shahi, Wang, Nuochuan, Guo, Shuaiwei, Liu, Yang, Zhang, Yanan, Li, Xiong, Wu, Jun, Wang, Shuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Aging Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727252/
https://www.ncbi.nlm.nih.gov/pubmed/36506468
http://dx.doi.org/10.3389/fnagi.2022.1020224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727252/
https://www.ncbi.nlm.nih.gov/pubmed/36506468
http://dx.doi.org/10.3389/fnagi.2022.1020224

Ejemplares similares